These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 12945071

  • 1. Cyclo-oxygenase 2 inhibition in colorectal cancer therapy.
    Church RD, Fleshman JW, McLeod HL.
    Br J Surg; 2003 Sep; 90(9):1055-67. PubMed ID: 12945071
    [Abstract] [Full Text] [Related]

  • 2. Use of NSAIDs for the chemoprevention of colorectal cancer.
    Herendeen JM, Lindley C.
    Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
    [Abstract] [Full Text] [Related]

  • 3. Cyclo-oxygenase 2 inhibitors: emerging roles in the gut.
    Grover JK, Yadav S, Vats V, Joshi YK.
    Int J Colorectal Dis; 2003 Jul; 18(4):279-91. PubMed ID: 12774242
    [Abstract] [Full Text] [Related]

  • 4. COX-2 inhibition as a tool to treat and prevent colorectal cancer.
    Tuynman JB, Peppelenbosch MP, Richel DJ.
    Crit Rev Oncol Hematol; 2004 Nov; 52(2):81-101. PubMed ID: 15501074
    [Abstract] [Full Text] [Related]

  • 5. COX-2 inhibitors: a potential target for drug therapy in the management of colorectal cancer.
    Ryan AR, Rosita AR, Kamarul AK, Qureshi A.
    Med J Malaysia; 1999 Sep; 54(3):293-5. PubMed ID: 11045053
    [Abstract] [Full Text] [Related]

  • 6. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
    Tuynman JB, Hulscher JB, Steller EP, van Lanschot JJ, Richel DJ.
    Ned Tijdschr Geneeskd; 2003 Nov 08; 147(45):2207-12. PubMed ID: 14640057
    [Abstract] [Full Text] [Related]

  • 7. COX-2 inhibition and prevention of cancer.
    Giercksky KE.
    Best Pract Res Clin Gastroenterol; 2001 Oct 08; 15(5):821-33. PubMed ID: 11566043
    [Abstract] [Full Text] [Related]

  • 8. Cyclooxygenase-2 inhibition in colorectal cancer: boom or bust?
    Sanborn R, Blanke CD.
    Semin Oncol; 2005 Feb 08; 32(1):69-75. PubMed ID: 15726508
    [Abstract] [Full Text] [Related]

  • 9. Prevention of colorectal cancer through the use of COX-2 selective inhibitors.
    Peek RM.
    Cancer Chemother Pharmacol; 2004 Sep 08; 54 Suppl 1():S50-6. PubMed ID: 15309515
    [Abstract] [Full Text] [Related]

  • 10. [Prevention of colorectal cancer: acetylsalicyclic acid and cyclo-oxygenase-2 inhibitors are only partially effective].
    Kleibeuker JH, de Vries EG.
    Ned Tijdschr Geneeskd; 2003 Nov 08; 147(45):2203-7. PubMed ID: 14640056
    [Abstract] [Full Text] [Related]

  • 11. Cyclo-oxygenase 2 inhibition in colorectal cancer therapy (Br J Surg 2003; 90: 1055-1067).
    Nash G.
    Br J Surg; 2003 Dec 08; 90(12):1610. PubMed ID: 14648750
    [No Abstract] [Full Text] [Related]

  • 12. Gene modulation by Cox-1 and Cox-2 specific inhibitors in human colorectal carcinoma cancer cells.
    Bottone FG, Martinez JM, Alston-Mills B, Eling TE.
    Carcinogenesis; 2004 Mar 08; 25(3):349-57. PubMed ID: 14633654
    [Abstract] [Full Text] [Related]

  • 13. COX-2: a molecular target for colorectal cancer prevention.
    Brown JR, DuBois RN.
    J Clin Oncol; 2005 Apr 20; 23(12):2840-55. PubMed ID: 15837998
    [Abstract] [Full Text] [Related]

  • 14. Glycine-extended gastrin stimulates proliferation and inhibits apoptosis in colon cancer cells via cyclo-oxygenase-independent pathways.
    Ogunwobi OO, Beales IL.
    Regul Pept; 2006 Mar 15; 134(1):1-8. PubMed ID: 16169610
    [Abstract] [Full Text] [Related]

  • 15. [Cyclooxygenase 2 inhibitors and colorectal cancer].
    Bernardeau-Mozer M, Chaussade S.
    Bull Cancer; 2004 May 15; 91 Spec No():S89-98. PubMed ID: 15239336
    [Abstract] [Full Text] [Related]

  • 16. Transcriptional regulation of cyclo-oxygenase expression: three pillars of control.
    Ramsay RG, Ciznadija D, Vanevski M, Mantamadiotis T.
    Int J Immunopathol Pharmacol; 2003 May 15; 16(2 Suppl):59-67. PubMed ID: 14552705
    [Abstract] [Full Text] [Related]

  • 17. [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications].
    Wülfing C, Eltze E, Von Struensee D, Wülfing P, Bode ME, Bettendorf O, Piechota H, Hertle L.
    Aktuelle Urol; 2004 Aug 15; 35(4):331-8. PubMed ID: 15459875
    [Abstract] [Full Text] [Related]

  • 18. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway.
    Calviello G, Di Nicuolo F, Gragnoli S, Piccioni E, Serini S, Maggiano N, Tringali G, Navarra P, Ranelletti FO, Palozza P.
    Carcinogenesis; 2004 Dec 15; 25(12):2303-10. PubMed ID: 15358633
    [Abstract] [Full Text] [Related]

  • 19. Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells.
    Lin J, Hsiao PW, Chiu TH, Chao JI.
    Biochem Pharmacol; 2005 Sep 01; 70(5):658-67. PubMed ID: 16004971
    [Abstract] [Full Text] [Related]

  • 20. Prospects in NSAID-derived chemoprevention of colorectal cancer.
    Chell S, Patsos HA, Qualtrough D, H-Zadeh AM, Hicks DJ, Kaidi A, Witherden IR, Williams AC, Paraskeva C.
    Biochem Soc Trans; 2005 Aug 01; 33(Pt 4):667-71. PubMed ID: 16042570
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.